Mechanisms of alcoholic liver injury

Canadian Journal of Gastroenterology

Volumn 14, Issue 4, 2000, Pages 327-332

  French, Samuel W ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

Cytokines; Ethanol; Growth factors; Kupffer cells; Stellate cells

Indexed keywords

CYTOKINE; ENDOTOXIN; NEOMYCIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHOSPHATASE; PROTEASOME; PROTEIN KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SATURATED FATTY ACID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UBIQUITIN;

ALCOHOL LIVER DISEASE; BILE DUCT; CELL SIZE; DIETARY INTAKE; ENZYME ACTIVATION; ENZYME INHIBITION; FAT INTAKE; HEPATITIS; HUMAN; INTESTINE FLORA; KNOCKOUT MOUSE; KUPFFER CELL; LACTOBACILLUS; LIVER CELL; MALLORY BODY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STELLATE CELL;

EID: 0034103739     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/801735     Document Type: Review

References (67)

1. Lands WFM. Cellular signals in alcohol-induced liver injury: A review. Alcohol Clin Exp Res 1995;19:928-38.
2. 2. Am J Pathol 1993;142:367-73.
3. Nanji A, Khettry U, Sadrzadeh S. Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver disease. Proc Soc Exp Biol 1994;205:243-7.
4. Adachi Y, Moore L, Bradford B, Thurman R. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 1995;108:218-24.
5. Adachi Y, Bradford B, Gao W, Thurman R. Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 1994;20:453-60.
6. McClain CJ, Hill DB, Schmidt J. Cytokines and alcoholic liver disease. Semin Liver Dis 1993;13:170-82.
7. Hill D, Shedofsky S, McClain CJ. Cytokines and liver disease. In: Remick D, Friedland J, eds. A Cytokines in Health and Disease, 2nd edn. New York: Marcel Dekker, Inc, 1997:401-25.
8. Nanji AA, Zhao S, Sadrzadeh SM. Use of reverse transcription-polymerase chain reaction to evaluate in vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology 1994;19:1483-7.
9. Kaminura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995;21:1304-9.
10. Imuro Y, Gallucci R, Luster ML, Kano H, Thurman RG. Antibodies to tumor necrosis factor alpha attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat. Hepatology 1997;26:1530-7.
11. Yin M, Kono H, Bradford BU, Thurman RO. Development of a new enterai mouse model using knock out technology to study alcohol-induced liver injury: involvement of TNFα. Hepatology 1998;28:321. (Abst)
12. Hoek JB, Kholodenko BN. The intracellular signaling network as a target for ethanol. Alcohol Clin Exp Res 1998;22:224S-30S.
13. Nanji AA, Miao L, Thomas P, et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 1997;112:943-51.
14. Enomoto N, Ikejima K, Bradford B, et al. Alcohol causes both tolerance and sensitization of rat Kupffer cells via mechanisms dependent on endotoxin. Gastroenterology 1998;115:443-51.
15. Tsukamoto H, Lin M, Ohata M, Giulivi C, French SW, Brittenham G. Iron primes for hepatic macrophages NpκB activation in alcoholic liver injury. Am J Physiol 1999;277:G1240-50.
16. Jokelainen K, Lindros KO, Nanji AA. Increased acetaldehyde in vivo inhibits NFκB activation through IKBα preservation and ameliorates liver injury in experimental alcoholic liver disease. Hepatology 1998;28:499. (Abst)
17. Tsukamoto H, Home W, Kamimura S, et al. Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 1995;96:620-30.
18. Yacoub LK, Fogt F, Geriniuviene B, Nanji AA. Apoptosis and Bcl-2 protein expression in experimental alcoholic liver disease in the rat. Alcohol Clin Exp Res 1995;19:854-9.
19. French SW, Nash J, Shitabata P, et al. Pathology of alcoholic liver disease. Semin Liver Dis 1993;13:154-69.
20. Reed JC. Cytochrome C: Can't live with it - can't live without it. Cell 1997;91:559-62.
21. Colell A, Garcia-Ruiz C, Kaplowitz N, Fernandez-Chica JC. Hepatic mitochondrial glutathione depletion and cytokine-mediated alcoholic liver disease. Alcohol Clin Exp Res 1998;22:27-8.
22. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 1995;67:101-54.
23. French SW, Morimoto M, Reitz R, et al. Lipid peroxidation, CYP2E1 and fatty acid metabolism in alcoholic liver disease. J Nutr 1997;127:9075-115.
24. Albano E, Clot P, Morimoto M, Tamasi A, Ingelman-Sundberg M, French SW. Role of cytochrome P450 2E1-dependent formation of hydroxyethyl free radicals in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 1996;23:155-63.
25. Albano E, French SW, Ingelman-Sundberg M. Cytochrome P450 2E1, hydroxyethyl free radicals and immune reactions associated to alcoholic liver disease. Alcohol Clin Exp Res 1998;22:739-42.
26. Amet Y, Lucas D, Zhang-Gouillon ZQ, French SW. P450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes. Alcohol Clin Exp Res 1998;22:455-62.
27. Amet Y, Berthou F, French SW. Alcohol-inducible P450 in rat liver and kidney microsomes. Fatty acid metabolism. Alcohol Clin Exp Res 1998;22:744-6.
28. Lytton SD, Helander A, Zhang-Gouillon ZQ, et al. Autoantibodies against cytochromes P-4502E1 and P-4503A in alcoholics. Mol Pharmacol 1999;55:223-33.
29. Dean RT, Fu S, Stocker R, Davies MJ. Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997;324:1-18.
30. Zhang-Gouillon ZQ, Yuan QX, French BA, et al. Effects of DB-cAMP on ubiquitin and CYP2E1 levels in experimental ethanol-induced liver disease. Hepatology 1996;24:442. (Abst)
31. Donohue TM Jr, Zetterman RK, Zhang-Gouillon ZQ, French SW. Peptidase activities of the multicatalytic protease in rat liver after voluntary and intragastric ethanol administration. Hepatology 1998;28:486-91.
32. Grune T, Reinheckel T, Davies KJA. Degradation of oxidized proteins in mammalian cells. FASEB J 1997;11:526-34.
33. Wieland P, Lauterburg BH. Oxidation of mitochondrial proteins and DNA following administration of ethanol. Biochem Biophys Res Commun 1995;213:815-9.
34. Fromenty B, Grimbe TS, Mansowie A, et al Hepatic mitochondrial DNA deletion in alcoholics: association microvesicular steatosis. Gastroenterology 1995;108:193-200.
35. Mansowi A, Fromenty B, Berson A, et al. Multiple hepatic DNA deletions suggest premature oxidative aging in alcoholics. J Hepatol 1997;27:96-102.
36. Tsutsumi M, Tsuchishima M, Shiroeda K, Deshima Y, Kawahara H, Takase S. Reversibility of mitochondrial DNA mutation in alcoholic liver disease. Hepatology 1998;28:669. (Abst)
37. Friedman SL. Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterology 1997;32:424-30.
38. Janagen WR, Rockey DC, Koteliansk VE, Wang SS, Bissell DM. Expression of variant fibronectins in wound healing. Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994;127:2037-48.
39. Gillis SE, Nagy LE. Deposition of cellular fibronectin increases before stellate activation in rat liver during ethanol feeding. Alcohol Clin Exp 1997;21:857-61.
40. Urashima S, Tsutsumi M, Nakase K, Wang J-S, Takada A. Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol 1993;28:77-84.
41. Takahashi H, Wang K, Jui L, Nanji AA, Mendenhall CS, French SW. Effect of dietary fat on lto cell activation by chronic ethanol intake: A long-term serial morphometric study on alcohol-fed and control rats. Alcohol Clin Exp Res 1991;15:1060-6.
42. Nanji AA, Mendenhall CL, French SW. Beef fat prevents alcoholic liver disease in the rat. Alcohol Clin Exp Res 1989;13:15-9.
43. Morimoto M, Zern MA, Hagbjork A-L, Ingelman-Sundberg M, French SW. Fish oil, alcohol and liver pathology. Role of cytochrome P450 2E1. Proc Soc Exp Biol Med 1994;207:197-205.
44. French SW, Takahashi H, Wong K, Mendenhall C. Ito cell activation induced by chronic ethanol feeding in the presence of different dietary fats. Alcohol Alcohol 1991;26(Suppl):357-61.
45. Rockey DC, Maher JJ, Jarnagen WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatology 1992;16:776-84.
46. Hogemann B, Domschke W. Hepatic fibrosis-current concepts of pathogenesis and therapy. Gastroenterol Jpn 1993;28:570-9.
47. Herbst H, Wege T, Milani S, et al. Tissue inhibition of metalloproteinase-1 and 2 RNA expression in rat and human liver fibrosis. Am J Pathol 1997;150:1647-59.
48. Nanji AA, Tahan SR, Khwaja S, Yacoub LK, Sadrzadeh SMH. Elevated plasma levels of hyaluronic acid indicate endothelial dysfunction in the initial stages of alcoholic liver disease in the rat. J Hepatol 1996;24:368-74.
49. Bissell DM, Wang FS, Timmons C. Expression of the hyaluronate receptor CD44 by liver stellate cells: Splice isoforms in wound repair and role in cell migration. Mol Biol Cell 1997;8:396. (Abst)
50. Bauer M, Paquette NC, Zhang JX, et al. Chronic ethanol consumption increases hepatic sinusoidal contractile response to endothelin-1 in the rat. Hepatology 1995;22:1565-76.
51. French SW, Benson NC, Sun PS. Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology 1984;4:912-7.
52. Ray MB, Mendenhall CL, French SW, Gartside PS. The nature of bile duct changes in alcoholic liver disease. Liver 1993;13:36-45.
53. Cocjin J, Rosenthal P, Bulson V, et al. Bile ductule formation in fetal neonatal and infant livers compared with extrahepatic biliary atresia. Hepatology 1996;24:568-74.
54. Thorgiersson SS. Hepatic stem cells in liver regeneration. FASEB J 1996;10:1249-56.
55. Fuji K, Evarts RP, Hu Z, Marsden ER, Thorgeirsson SC. Expression of stem cell factor and its receptor c-kit during liver regeneration from putative stem cells in adult rat. Lab Invest 1994;70:511-6.
56. Rockey DC, Fovassier L, Chung JJ, et al. Cellular localization of endothelin-1 and increased production in liver injury in the rat: Potential for autocrine and paracrine effects on stellate cells. Hepatology 1998;27:472-80.
57. Omori M, Evarts RP, Omori N, Hu Z, Marsden ER, Thorgierson SS. Expression of α-fetoprotein and stem cell factor/c-kit system in bile duct ligated young rats. Hepatology 1997;25:1115-22.
58. Matsumoto K, Fuji H, Michalopoulus C, Fung JJ, Demetris AJ. Human biliary epithelial cells secretic and respond to cytokines, and hepatocytic growth factors in vitro: Interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. Hepatology 1994;20:376-82.
59. Zhang-Gouillon ZQ, Yuan QX, Hu B, et al. Mallory body formation by ethanol feeding in drug-primed mice. Hepatology 1998;27:116-22.
60. Yuan QX, Nagao Y, Gaal K, Hu B, French SW. Mechanisms of Mallory body formation induced by okadaic acid in drug primed mice. Exp Mol Pathol 1998;65:87-103.
61. Kachi K, Wong PTT, French SW. Molecular structural changes in Mallory body protein in human and mouse livers. An infrared spectroscopy study. Exp Mol Pathol 1993;59:187-210.
62. Ohta M, Marceau N, Perry C, et al. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes. Lab Invest 1988;59:848-56.
63. Kawahara H, Cadrin M, French SW. Ethanol-induced phosphorylation of cytokeratin in cultured hepatocytes. Life Sci 1990;47;859-63.
64. French SW. Cytoskeleton: Intermediate filaments. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. the Liver: Biology and Pathobiology, 3rd edn. New York: Raven Press, 1994:33-44.
65. Sun SC, Magqirwar SR, Harhad E. Activation of NF kappa b by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites. J Biol Chem 1995;270:18347-51.
66. Stumptner C, Omary MB, Denk H, Zatloukal K. Changes in the phosphorylation of the hepatic keratins 8/18 in human alcoholic hepatitis and in experimentally intoxicated mouse liver. Hepatology 1998;28:512. (Abst)
67. Guertl B, Stumptner C, Zatloukal K, Denk H. Role of protein kinases and phosphatases in the pathogenesis of liver disease and related animal models. Hepatology 1998;28:638. (Abst)